Subscribe
istock-839222794-nicoelnino-1
NicoElnino / iStockphoto.com
27 July 2018Americas

GSK unites with 23andMe amid R&D revamp

GSK revealed its new approach to research and development (R&D) earlier this week, including a partnership with DNA testing company 23andMe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
GSK unites with CRISPR pioneer Doudna
14 June 2019   British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Americas
FDA orders 23andMe to cease PGS sales
26 November 2013   The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.
Americas
23andMe’s ‘designer baby’ patent sparks controversy
8 October 2013   Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
GSK unites with CRISPR pioneer Doudna
14 June 2019   British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Americas
FDA orders 23andMe to cease PGS sales
26 November 2013   The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.
Americas
23andMe’s ‘designer baby’ patent sparks controversy
8 October 2013   Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.

More on this story

Americas
GSK unites with CRISPR pioneer Doudna
14 June 2019   British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Americas
FDA orders 23andMe to cease PGS sales
26 November 2013   The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.
Americas
23andMe’s ‘designer baby’ patent sparks controversy
8 October 2013   Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB